Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
683
-
Total 13F shares, excl. options
-
179,150,369
-
Shares change
-
+349,858
-
Total reported value, excl. options
-
$21,579,770,911
-
Value change
-
+$89,320,468
-
Put/Call ratio
-
51%
-
Number of buys
-
297
-
Number of sells
-
-320
-
Price
-
$120.56
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2016
778 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q3 2016.
Edwards Lifesciences Corp - Common Stock (EW) has 683 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179,150,369 shares
of 590,231,680 outstanding shares and own 30% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (19,275,273 shares), FMR LLC (10,729,659 shares), SANDS CAPITAL MANAGEMENT, LLC (9,035,637 shares), STATE STREET CORP (8,821,251 shares), Capital Research Global Investors (6,427,014 shares), BlackRock Institutional Trust Company, N.A. (5,542,619 shares), BlackRock Fund Advisors (4,337,584 shares), AMERIPRISE FINANCIAL INC (4,320,603 shares), WELLINGTON MANAGEMENT GROUP LLP (3,704,254 shares), and FRANKLIN RESOURCES INC (3,008,961 shares).
This table shows the top 683 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.